A secure platform connecting science, medicine, and innovation
A diverse ecosystem of stakeholders united in advancing RNA therapeutic development.
Advancing fundamental research and training future scientists.
A structured, transparent process from research submission to pipeline advancement
Researchers submit RNA therapeutic concepts with scientific rationale, target indications, and preliminary data.
Expert panel reviews submissions for scientific merit, feasibility, and alignment with platform objectives.
Multi-stakeholder teams form around validated projects. Roles assigned, resources allocated.
Real-time project management with task boards, milestones, deliverables, and progress visualization.
Current therapeutic development faces systemic challenges that slow innovation and increase costs.
End-to-end encryption, role-based permissions, HIPAA-aware data handling for sensitive research materials.
Live progress dashboards, milestone monitoring, resource allocation visibility across all active projects.
Agile project boards, task assignment, sprint planning, dependency mapping for complex research workflows.
Granular permissions system ensuring appropriate access levels for researchers, clinicians, partners, and administrators.
Moderated scientific forums, peer review workflows, expert consultation channels, knowledge base integration.
Personal research notebooks, team-shared documentation, version control, annotation and commenting systems.
Secure internal messaging, threaded discussions, file sharing, video call integration for distributed teams.
Seamless workflow synchronization with Monday.com for organizations already using enterprise project management tools.
Trust through transparency, security through design, compliance through architecture
Identity verification, credential validation, and institutional affiliations confirmed for all platform participants.
AlterRNA adheres to international standards for data protection, security, and healthcare compliance
Measurable outcomes from a collaborative, transparent approach to RNA therapeutic development
Reduced development cycles through parallel collaboration and shared infrastructure
Shared resources, open science principles, and collaborative funding models
Cost-effective development enables pricing strategies focused on patient access
Worldwide network of researchers, institutions, and partners advancing RNA therapeutics
Traditional pharmaceutical development models are characterized by siloed research, proprietary competition, and limited stakeholder engagement. This approach results in extended timelines, duplicated efforts, and ultimately, therapies that may be inaccessible to patients who need them most.
AlterRNA’s collaborative platform represents a paradigm shift: transparent research processes, shared learnings, multi-stakeholder input from inception, and a fundamental commitment to developing affordable RNA therapeutics.
By connecting researchers, clinicians, patients, and institutional partners in a secure, governed environment, we accelerate the path from scientific discovery to clinical application—while maintaining the rigorous standards required for safe, effective therapeutics.
Shared knowledge, collaborative validation
Development guided by real- world needs
Efficiency enabling accessibility
Submit research ideas, collaborate globally, and contribute to the development of affordable RNA therapeutics.
Partner with AlterRNA to support collaborative research, provide validation services, or explore licensing opportunities.